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Abstract Copper(II) complexes of several hydroxyflavones were prepared and characterised through their
physico-chemical properties. The nuclease activity of three synthesised complexes is reported. These
copper(II) complexes present more nuclease activity than the ligands and the copper(II) ion.
INTRODUCTION
The flavonoids are a group of natural substances reported as being present in all higher plants. The
basic flavone structure consists of 1,4-benzopyrone with phenyl substitution in position 2. The different
groups of flavonoids differ in the number and position of substitutents on the aromatic ring, and in the extent
and character of the oxidation on the pyrone portion of the molecule. Through their hydroxyl groups, the
flavonoids are able to combine with sugars to form glycosides. In this sense, over 4000 different species of
flavonoids have been described in fruits and vegetables, seeds, stems and flowers. They are therefore
important component of the human diet. On average, a mixed Western diet supplies about g of flavonoids
daily. The flavonoids exhibit a broad range of biochemical and pharmacological effects, some of which
suggesting that a number of compounds of this group may affect the different cell systems. The flavonoids
are probably the most common and active antioxidants in the human diet. In this sense, they are active both
in hydrophilic and lipophilic systems. The mechanism responsible for the antioxidant activity appears to be
dual. On one hand, they act as free radical scavengers, and on the other hand they are able to chelate metal
ions, thereby reducing metal induced peroxidation.
Today it is known that the excessive production of free radicals and lipid peroxidation may be
implicated in the development of certain chronic diseases such as atherosclerosis and cancer.
The quercetin (3’,4’,5,7-tetrahydroxyflavonol) and other 3-hydroxyflavones are degraded to depside
and carbon monoxide by the quercetinase, a dioxygenase produced by the Aspergillusflavus. Quercetinase
is a Cu(II)-containing dioxygenase. A Cu(II) chelate of quercetin is the key intermediate in the enzymatic
reaction. In order to determine if the mode of coordination of flavones may give information relevant to the
enzyme-quercetine interaction, Speier et al
3"s prepared copper(I) and copper (If) binary and ternary
complexes of 3-hydroxyflavone, where the flavone interacts with the Cu(II) through the Ohydrox and the
Ocarbonyl atoms. The synthesis and physicochemical properties of M(II) (Co, Ni and Cu) complexes with 5,7-
dyhroxyflavone was reported.9’1
On the other hand, Hadi et al.TM have shown that quercetin and other flavonoids cause strand
scission in DNA in the presence of Cu(II) and that his reaction is associated with transient reduction of
Cu(II) to Cu(1) and the generation of active species. Of the several metal ion tested [Cu(II), Fe(II), Fe(IIl),
Co(II), Mn(II), Ni(II) and Ca(II)] only Cu(II) and Fe(III) complemented quercetin in the DNA breakage
reaction. They proposed that the formation of a ternary complex of quercetin, DNA and Cu(II)/Cu(l) is
involved in the generation of the oxygen active species that are the cause of the strand of DNA. A similar
reaction dependent of metal ions and involving oxygen radicals has been reported with 1,10-phenantroline.
3
DNA-directed sequence-specific reagents capable of controlled chemical cleavage may also serve as
molecular biological tools, either in the sense of standard but artificial restriction endonucleases or for a
larger scale genome mapping.
With this in mind, it is important to develop not only novel DNA sequence reading molecules, but
also chemical cleavage systems which are easily amenable to chemical synthesis manipulation and have
suitably biocompatibility (e.g. stability, cellular penetration, recycling).
4 Recently several papers about the
nuclease activity of copper complexes were reported.
15.26
Until now no paper concerning the nuclease activity of the copper complexes of flavones has been
reported.
In the present paper we describe the synthesis and characterisation of a number of copper complexes
of flavones (their structure is summarised in Figure 1) and the nuclease activity of three copper-flavone
complexes. The antioxidant activity ofthese flavones were recently described.
27











RI=OH R R3= R4 H
R1 =R4=H R R3 OH
R =R=H R3 R4 OH
Figure 1. Structure ofhydroxyflavones
MATERIALS AND METHODS
The flavonoids 3-hydroxyflavone (H3HF), 5,7-dihydroxyflavone (H25,7DHF), 7,8-dihydroxyflavone
(H27,SDHF) were from Apin Chemicals Ltd. Cu(II) salts, hydrogen peroxide, ascorbic acid, bromophenol
blue and ethidium bromide from Sigma Chemical Co. Plasmid pBR322 and agarose was purchased from
Boehringer Manhein. Plasmid pUCI was a gift of the Departamento de Bioquimica de la Universitat de
Valencia.
UV-Vis data were obtained on a Shidmazu 2101-PC instrument, while the infrared spectra were
recorded as KBr disk on a Mattson Satellite Ftir spectrometer. X-band EPR spectra were collected at room
temperature on a Bruker ER D200 spectrometer.
Synthesis of complexes
Cu(3HF)2 Cu(H5,7DHF)2(MeOH)2 Cu(7,8DHF)(H20)2.-
mmol of copper acetate, was dissolved in 50 ml of MeOH. A different amount of H3HF, H25,7DHF and
Hz7,SDHF according to molar ratios metal flavone (Cu :H3HF Cu H25,7DHF and Cu
H27,SDHF 2:1) was then added with stirring. After several hours solids were obtained, which were
filtered and air-dried.
Anal. for Cu(3H,F)2, Found C 66.2 H 3.6 Cu 11.3 Calc. for C30HI806Cu C 66.9 H 3.4 Cu 11.8 IR
bands 1590 cm" Vst(C=O) 1210 810 cm v(-C-O-C-).
Anal. for Cu(H5,7DHF)(Me,OH)2, Found C 60.4 H 4.0 Cu 9.7. Calc. for C32H26OIoCu C 60.6 H 4.1
Cu 10.0 IR band 1630 cm" Vst(C=O) 1060 840 cm v(-C-O-C-).
Anal. for Cu(7,8DHF)(H,O)2, Found C 50.8 H 3.2 Cu 18.1 Calc. for CIsH206Cu C 51.2 H 3.4 Cu
18.1. IR bands 1620 cm" vst(C=O) 1080 820 cm" v(-C-O-C-)
Cu(7,8DHF)(MeOH)
To a 50 ml of a methanolic solution containing mmol of Cu(OCH3)2, mmol of Hz7,8DHF was added
with continuous stirring. After an hour approximately it appears a brown solid which is filtered, washed with
methanol and air-dried.
Anal. Found C 54.9 H 3.2 :Cu 17.7 Calc. for C6H2OsCu C 55.2 H 3.5 Cu 18.3. IR bands" 1620
cm" Vst(C=O) 1080 820 cm"1 v(-C-O-C-).
Cu(H5,7DHF)2 (H20).,
To a 25 ml of a methanolic solution of Cu(CIO4)2.6H20, mmol of the 5,7H2DHF was added with stirring.
After 30 min, 0.5 ml of butylamine (30%) was added. Immediately a yellow solid appeared, that was filtered,
washed with methanol and air-dried until constant weight.
Anal. Found C 59.2 H 3.6 Cu 10.6 Calc. for C30H2200Cu" C 59.5 H 3.7 Cu 10.5. IR bands: 1620
cm
"t Vst(C=O) 1080 820 cm v(-C-O-C-).
Cu(3HF)2(NH3)(H20) and Cu(7,8DHF)(NH3)2(H20)3.-
To a 25 ml of a methanolic solution of Cu(CIOa)2.6H20, mmol of the H3HF or H27,8DHF was added with
stirring. After 30 min, 0.5 ml of concentrated NH3 (30%) was added. Immediately yellow and brown solids
respectively appeared, that were filtered, washed with methanol and air-dried until constant weight.
Anal for Cu(3HF)(NH3)(H20), found C 62.8,; H 3.8 N 2.4 Cu 11.4. Calc. for C3oH’,;NOTCu C 62.9 H
4.0 N 2.4 Cu 11.1. IR bands: 3360, 3280 cm" vst(N-H) 1620 cm Vst(C=O) 1210; 8i3 cm v(-C-O-C-).
Anal. for Cu(7,SDHF)(NH3)2(H.-,O)3, found C 43.8 H 4.9 N 6.4 Cu 16.0. Found for CsH-,oN.,O7Cu
44.6, H 5.0 N 6.9 Cu 15.7. IR bands 3360, 3240 cm" vst(N-H) 1620 cm" Vst(C=O) 1080 810 cm
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v(-c-o-c-)
Cleavage of pBR322 and pUCI by Cu(II)-7,8DHF complexes
A typical reaction was carried out by mixing 16 t-tl of the Cu(II) complex 0.625 tM in buffer Tris-
HCI pH 8, 2 tl of 0.25 g/ktl pBR322 or pUCI and 2 ktl of H202 500 tM. The resulting solution contains
0.5 M of the complex, 0.025 lag/ktl pBR322 or pUCI and 50 t,tM of H202. After allowing the sample to
incubate at 25 C for a 30 min, 3/al of a quench buffer solution consisting of a 0.2% bromophenol blue, 24%
glycerol and mM edta, was added. Then the solution was subjected to electrophoresis on a 1% agarose gel
in lx TBE buffer (0.1M tris borate, 0.2 mM edta) at 80 V about 4 h: The gel was stained with 0.5 lag/ml
ethidium bromide and photographed on a UV transilluminator with a Polaroid camera MP4 containing an
Agfapan (negative/positive) film.
RESULTS AND DISCUSSION
The band assigned to v(O-H) of the H3HF disappears in the IR spectrum of the Cu(3HF)2 complex. In
the IR spectra of the rest of the synthesised complexes the existence of water or methanol molecules does
not permit suggestions about the band attributed to v(O-H).
A shift of 20 cm
1 is observed for the band attributed to v(C=O) in the IR spectra of the complexes
with respect to the ligands.
The v(C-O-C) bands remain unchanged in the metal complexes of H3HF an H25,7DHF with respect
to the IR spectra of the ligands. However a shift of these vibrations take place in the IR spectra of the metal
complexes of H27,8DHF (1080 in the complexes and 1160 cm" in the ligand). This is probably due to the
deprotonation and coordination of the hydroxo groups at C7 and C8, neighbour of the C9-0-C 10 group.
The complexes Cu(3HF)e(NH3)(HeO) and Cu(7,8 DHF)(NH3)E(HeO)3 show two peaks at 3360 and
3280 cm
1 corresponding to v(N-H) ofammonia.
According to the IR spectra it is possible to conclude that the 3HF" interacts with the Cu (II) ion as a
bidentate ligand through the Ocarbony and Ohydroxo atoms in similarly as for the copper flavonolate complex.
Probably, the H5,7DHF anion links to Cu(II) in a similar manner, while the 7,8DHF
e" anion must interact
with Cu(II) through the contiguous deprotonated OH.
The electronic spectra of all the copper(II) complexes exhibit in the solid state one major absorption
band in the 12500-20000 cm
1 region. This band is attributed to d-d transitions in an octahedral geometry or
a square pyramidal distorted structure. One band at 22500-24500 cm" is attributed to a charge-transfer
transition from the flavonolato ligand to the metal atom. Furthermore, the complexes show an intraligand
transition around 42000 cm.
The values of the magnetic moments at room temperature of the copper complexes of the H3HF and
H25,7DHF are in the normal range for Cu(II) complexes without metal-metal interaction (1.74-1.93 MB).
The magnetic moment values at room temperature of Cu(7,8DHF)(H20): and Cu(7,8DHF)(MeOH) are 1.43
and 1.40 MB respectively, suggesting metal-metal antiferromagnetic interaction. The complex Cu(7,8
DHF)(NH3)e(HeO)3 shows t 1.78 MB in the normal range for Cu(II) mononuclear complexes.
The polycrystalline EPR spectra of the complexes of copper at room temperature are axial The
simulation of the EPR spectrum of the Cu(3HF)2 complex show gll 2.25 and g_ 2.07 and tlat of
Cu(3HF)e(NH3)(H20) complex are 2.25 and 2.08, suggesting that the unpaired electron must be in dxe.ye (or
dxy) orbital. The EPR spectrum of the Cu(HS,7DHF)e(MeOH)2 complex is axial with a weak hyperfine
coupling. The EPR parameters are gll 2.16 and g_ 2.04, while the value of the parallel hyperfine coupling
4 constant All is about 160.10 cm. The value of gll All quotient of 135 permits us to deduce an distorted
octahedral environment around the Cu(II) ion.
29 Similar EPR parameters can be deduced from the EPR
spectrum of the obtained Cu(HS,7DHF)e (H20)2 complex (gll 2.22, gl 2.03 and All 166.10
.4 cm). The
EPR spectrum of Cu(7,8DHF)(NH3)2(HeO)3 is rhombic with gz. 2.47 gy 2.10 and g3 2.0. The EPR
spectra ofthe Cu(7,8DHF)(HeO)_ and Cu(7,8DHF)(MeOH) are practically silent.
Cleavage of pBR322 by Cu(7,8DHF)(NH3)2(HO)3, Cu(7,8DHF)(H:O): and Cu(7,8DHF)(MeOH)
complexes.-
The addition of Cu(7,8DHF)(NH3)z(H20)3 to pBR322 which is initially mostly supercoiled Form I, in
the presence of a 100 fold excess of H202 causes cleavage of the plasmid to give both nicked (single strand
break, ssb, Form II) and linear (double strand break, dsb, Form III) products. Figure 2 shows the progression
of the cleavage with increasing complex concentration, in the presence of H202 (pH=8 Y 25C). From
this figure we can appreciate that a final concentration of 50 or 75 laM of the complex gives optimum
cleavage in the presence of 5000 and 7500 tM H202 respectively, under this conditions, to give both nicked
and linear products. Above this concentration, linear products are further degraded as indicated by the smear
on the gel.





Figure 2. Cleavage of pBR322 in the presence of Cu(7,8DHF)(NH3)2(H20)3 complex and H202. Lane 1,
pBR322 control; lane 2, Cu(7,SDHF)(NH3)E(H20)3 comptex 10ktM + H202 mM lane 3,
Cu(7,SDHF)(NHa)E(H20)3 complex 501aM + H202 5mM lane 4, Cu(7,8DHF)(NH3)2(H20)3 complex
751aM + H202 7.5 mM.
The progression of the cleavage reaction with MPA (mercaptopropionic acid) was also examined.
Figure 3 shows that the complex is a chemical nuclease at 50 and 75 ktM, but as we compare with that of
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Figure 3. Cleavage of pBR322 in the presence of.Cu(7,8DHF)(NH3)2(H20)3 complex and MPA. Lane 1,
pBR322 control; lane 2, Cu(7,8DHF)(NH3)2(H20)3 complex 101aM + MPA mM lane 3,
Cu(7,SDHF)(NHa)E(H20)3 complex 501.tM + MPA 5mM lane 4, Cu(7,8DHF)(NH.3)2(H_O)3 complex
751aM + MPA 7.5 mM.
We tried to study the cleavage reaction of pBR322 in the presence of the other complex,
Cu(7,SDHF)(H.,O)2 in the same conditions as reported above. Figure 4 confirms the chemical nuclease
activity of this complex in the presence of H202 or MPA or ascorbic acid. From this figure we can observe
that the complex only shows nicked and linear forms in the complex concentration range from 20 to 40 tM.
If we compare its nuclease activity in presence of H202 or MPA or ascorbic acid, we can deduce that the
increasing activity order is ascorbic acid > H202 > MPA.
1 2 3 4 5 6 7 8 9101112131415
Figure 4. Cleavage of pBR322 in the presence of Cu(7,8DHF)(H20)2 complex and H202, MPA and ascorbic
acid(Asc). Lanes l, 6 and 11 pBR322 control; lane 2, Cu(7,8DHF)(H20)2 complex 20ktM + H202 2.0mM
lane 3, Cu(7,SDHF)(HzO)2 complex 25M + HEOz 2.SmM; lane 4, Cu(7,8DHF)(H20)2 complex 30tM +
H202 3.0 mM; lane 5, Cu(7,SDHF)(H20)2 complex 40ktM / H202 4.0mM; lane 7, Cu(7,8DHF)(H_,O)_,
complex 201.tM + MPA 2.0mM lane 8, Cu(7,SDHF)(H20)2 complex 25 M + MPA 2.SmM lane 9,
Cu(7,SDHF)(H20)2 complex 30M + MPA 3.0mM lane 10, Cu(7,8DHF)(H20)2 complex 40ktM + MPA
4.0mM lane 12, Cu(7,SDHF)(H20)2 complex 20ktM + Asc 2.0mM lane 13, Cu(7,8DHF)(H20)2 complex
25ktM + Asc 2.SmM; lane 14, Cu(7,8DHF)(H20)2 complex 30 laM + Asc 3.0 mM lane 15,
Cu(7,SDHF)(H20)2 complex 401,tM + asc 4.0 mM. Reactions were carried out with 0.025tug/ktl pBR322 at
pH 8 (Tris buffer), 25C for 30 min.
Several control reactions have been carried out to insure that the Cu(7,8DHF)(MeOH) complex is
responsible for the observed cleavage of pBR322. The amounts ofDNA reaction mixtures containing H202,
Cu(II) salts or Cu(7,8DHF)(MeOH) complex (or combinations thereof) are shown in Figure 5. From this we
can. conclude that the Cu(II) salts at concentrations between 20 to 40 ktM do not cause the cleavage of the
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plasmid. When we observe the lanes 6 and 9 corresponding to a mixtures of Cu(II) salt and H27,8DHF (lane
6 with a 30 laM and lane 9, 40M in Cu(II) and the flavone respectively) we can appreciate that the
cleavage reaction of DNA takes place.showing Form and Form II at different intensities, while when the
concentration is 20 l.tM (lane 3) the figure presents an electrophoretic way similar to that of the pattern as
consequence there are not nuclease activity. Lanes 4, 7 and l0 represent the cleavage reaction of pBR322 in
presence of the Cu(7,SDHF)(MeOH) at 20, 30 and 40 ktM. From lane 4 is clearly shown the nuclease
activity of the complex, increasing their activity when the concentration increases in the lanes 7 and 10. If
we compare lanes 3, 6 and 9 with lanes 4, 7 and 10, we can conclude that the complex has a more importnat
nuclease activity than the metal ion, the ligand or a mixture of both.
1 2 3 4 5 6 7 8 9 10




Figure 5. Cleavage of pBR322 by Cu(7,8DHF)(MeOH) in the presence of H202. Lanes (1) untreated
pBR322 (2) with added 20ktM Cu(II) salt and 2 mM H20 (3) with added 201aM [Cu(lI) salt + 7,8DHF]
and 2 mM H202; (4) with added 20ktM of the Cu(7,SDHF)(MeOH) complex and 2mM H202 (5) 30 ktM
Cu(II) salt and 3 mM H202 (6) 30 laM [Cu(II) salt + 7,SDHF] and 3 mM H202 (7) 30 M of the
Cu(7,SDHF)(MeOH) complex and 3 mM H202 (8) 40 laM Cu(II) salt and 4 mM H202. (9) 40 tU [Cu(lI)
salt and 7,8DHF] and 4 mM H202 (10) 40 laM of the Cu(7,SDHF)(MeOH) complex and 4 mM H202
Reactions were carried out with 0.025 ktg/l pBR322 at pH 8.0 (Tris buffer), 25C. for 30 min.
In order to assess some specificity, supercoiled pUCI plasmid DNAwas cleaved with the
Cu(7,SDHF)MeOH, followed by probing with EcoRI. (Figure 6). When we compare lanes and 2 that
correspond to a result of the cleavage in the presence of the complex (lane 1) and afterwards digested with








Figure 6. Cleavage of pUCI 8 by Cu(7,SDHF)(MeOH) complex in the presence of H202. Lanes (1) pUCI 8
treated with 50M of Cu(7,SDHF)(MeOH) complex and 50 mM of H202 (2) pUCI 8 treated with 50M of
Cu(7,8DHF)(MeOH) complex and 50 mM of HzO2 and following cleavage with EcoRl.
From these experiences we can conclude that the Cu(7,SDHF)(NH3)z(HzO)3, Cu(7,8DHF)(HzOh and
Cu(7,8DHF)(MeOH) complexes are chemical nucleases. We also plat, to continue to study the possible
specificity of the complex and the other related ones in the hope of discovering other potentially practical
inorganic nucleases.
Involvement ofthe Cu(1) in the reaction.-
We employed bathocuproine as an agent that sequesters Cu(1) selectively. The Cu(l)-bathocuproine
chelate has an absorption maximum at 480 nm. Under the conditions of our reaction, neither Cu(ll) nor
Hz7,8DHF interferes with the absorption maximum, whereas Hz7,SDHF and Cu(II) react to generate Cu(1)
that in the presence of bathocuproine, gives rise to the maximum at 480 nm (Figure 7). The implication of
these findings is that Cu(II) is reduced by H27,8DHF, which does not establish whether Cu(1) is an end-
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product or an intermediate in the reaction that occurs in the absence of sequestering compound. As we
obtain the solid complexes, we think that the Cu(I) is an intermediate that it is oxidised to Cu(II) and reacts






Figure 7. Detection of H27,8DHF-induced Cu(I) production by bathocuproine a) Bathocuproine+Cu(II)
0.1raM b) Bathocuproine + Cu(I)0.02mM c) Bathocuproine + H27,8DHF 0.02mM d) Bathocuproine +
Hz7,8DHF 0.02 mM + Cu (II) 0.04 mM. Bathocuproine was 0.1mM.
Our data establish that the copper complexes of H27,8DHF generate single-strand and double strand
breaks in the presence of reducing agents such as ascorbic acid, H2Oz or MPA. These complexes have more
nuclease activity than the mixtures of Cu(II) and Hz7,8DHF. If we observe the chemical formula of
H7,8DHF, we can observe the presence of two OH contiguously. Hadi ’z reported the nuclease activity of
the quercetin and other flavonoids in the presence of Cu(II) and oxygen and concluded that the presence of
two OH groups in positions 3’ and 4’ of the B ring is required for this activity. Our results indicate that the
two contiguous OH are necessary but they can occupy positions in the A ring also.
According the mechanisms proposed previously by Sigman3 and Hadi ’" for copper nucleases, we
suggest a similar one, where the flavone reduces the Cu(lI) to Cu(I) after that the complex is intercalated to
DNA and then reacts to HOz to give rise oxygen radical species and an oxidised form of Hz7,8DHF, that
may be a group of compounds. The radicals are the responsible for the DNA cleavage.
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